What is Pulse4pulse?
Pulse4pulse operates at the intersection of advanced medical diagnostics and preventative healthcare. The company specializes in onsite testing for cardiovascular and autonomic nervous system health, specifically targeting the early detection of chronic conditions in asymptomatic populations. By deploying state-of-the-art medical devices, Pulse4pulse provides actionable clinical insights that facilitate early intervention for conditions such as peripheral artery disease, hypertension, and diabetic neuropathy. This proactive approach not only improves patient outcomes but also addresses the systemic need to reduce reliance on costly, invasive medical procedures, positioning the firm as a critical player in the modern healthcare infrastructure.
How much funding has Pulse4pulse raised?
Pulse4pulse has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Pulse4pulse
PPP
Public-Private Partnership
What's next for Pulse4pulse?
Following this late-stage capital injection, Pulse4pulse is expected to scale its operational footprint and enhance its diagnostic service delivery. The strategic deployment of these funds will likely focus on expanding the reach of its medical device network and refining its data analytics capabilities to provide more granular patient reports. As the company transitions into this next phase of growth, the focus will remain on increasing market penetration and solidifying its role as a leader in chronic disease management. By leveraging this financial backing, Pulse4pulse aims to bridge the gap between early symptom identification and long-term patient compliance, ultimately driving value for both healthcare providers and the patients they serve.
See full Pulse4pulse company page
